Advances in Understanding Diabetic Kidney Disease Progression and the Mechanisms of Acupuncture Intervention

被引:0
作者
Shan, Jinyi [1 ]
Cao, Ziyi [2 ]
Yu, Siming [3 ]
机构
[1] Heilongjiang Univ Chinese Med, Sch Grad Studies, Harbin, Peoples R China
[2] Shaanxi Univ Chinese Med, Clin Med Coll Shaanxi 1, Xianyang, Shaanxi Provinc, Peoples R China
[3] Heilongjiang Univ Chinese Med, Nephropathy Dept, Affiliated Hosp 1, Harbin, Heilongjiang Pr, Peoples R China
来源
INTERNATIONAL JOURNAL OF GENERAL MEDICINE | 2024年 / 17卷
关键词
diabetic kidney disease; acupuncture; mechanism; progress;
D O I
10.2147/IJGM.S490049
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic kidney disease (DKD) is a form of kidney damage resulting from diabetes and represents a common, severe complication of the disease. Globally, DKD is a leading cause of chronic kidney disease (CKD). DKD occurs in both type 1 and type 2 diabetes patients, with early clinical manifestations including microalbuminuria and hypertension. As the condition progresses, symptoms such as massive proteinuria, hypoalbuminemia, and severe edema may appear. The key to treating DKD lies in controlling blood glucose and blood pressure, reducing proteinuria, and slowing the deterioration of kidney function. Acupuncture, a traditional Chinese medicine treatment, has shown some therapeutic effects on DKD through mechanisms such as regulating blood glucose, improving renal blood flow and microcirculation, antioxidation and anti-inflammation, and modulating gut microbiota.
引用
收藏
页码:5593 / 5609
页数:17
相关论文
共 116 条
  • [1] Urinary IgG, serum CX3CL1 and miRNA-152-3p: as predictors of nephropathy in Egyptian type 2 diabetic patients
    Abdou, Aml E.
    Anani, Haneya A. A.
    Ibrahim, Hanan F.
    Ebrahem, Eman Elshohat
    Seliem, Nora
    Youssef, Eman M., I
    Ghoraba, Niveen M.
    Hassan, Asmaa S.
    Ramadan, Marwa A. A.
    Mahmoud, Eman
    Issa, Shorouk
    Maghraby, Hend M.
    Abdelrahman, Eman K.
    Hassan, Hala Ali Mohammed
    [J]. TISSUE BARRIERS, 2022, 10 (03):
  • [2] Renoprotective effect of a novel combination of 6-gingerol and metformin in high-fat diet/streptozotocin-induced diabetic nephropathy in rats via targeting miRNA-146a, miRNA-223, TLR4/TRAF6/NLRP3 inflammasome pathway and HIF-1α
    Aboismaiel, Merna G.
    Amin, Mohamed N.
    Eissa, Laila A.
    [J]. BIOLOGICAL RESEARCH, 2024, 57 (01)
  • [3] Exploring aldose reductase inhibitors as promising therapeutic targets for diabetes-linked disabilities
    Ahmad, Saheem
    Ahmad, Mohammad Faizan Ali
    Khan, Saif
    Alouffi, Sultan
    Khan, Mahvish
    Prakash, Chander
    Khan, Mohd Wajid Ali
    Ansari, Irfan Ahmad
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 280
  • [4] The Clinical Characteristics of Normoalbuminuric Renal Insufficiency in Korean Type 2 Diabetic Patients: A Possible Early Stage Renal Complication
    An, Jee Hyun
    Cho, Young Min
    Yu, Hyeong Gon
    Jang, Hak Chul
    Park, Kyong Soo
    Kim, Seong Yeon
    Lee, Hong Kye
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2009, 24 : S75 - S81
  • [5] Re-understanding and focusing on normoalbuminuric diabetic kidney disease
    An, Na
    Wu, Bi-Tao
    Yang, Yu-Wei
    Huang, Zheng-Hong
    Feng, Jia-Fu
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [6] Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled trial
    Awal, Hassan B.
    Nandula, Seshagiri Rao
    Domingues, Cleyton C.
    Dore, Fiona J.
    Kundu, Nabanita
    Brichacek, Beda
    Fakhri, Mona
    Elzarki, Adrian
    Ahmadi, Neeki
    Safai, Shauna
    Fosso, Magan
    Amdur, Richard L.
    Sen, Sabyasachi
    [J]. CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [7] Efficacy and safety of liraglutide compared to sulphonylurea during Ramadan in patients with type 2 diabetes (LIRA-Ramadan): a randomized trial
    Azar, S. T.
    Echtay, A.
    Bebakar, W. M. Wan
    Al Araj, S.
    Berrah, A.
    Omar, M.
    Mutha, A.
    Tornoe, K.
    Kaltoft, M. S.
    Shehadeh, N.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (10) : 1025 - 1033
  • [8] Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets
    Barrera-Chimal, Jonatan
    Jaisser, Frederic
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 : 16 - 31
  • [9] Comparative Study of Significance of Serum Cystatin-C, Serum Creatinine and Microalbuminuria Estimation in Patients of Early Diabetic Nephropathy
    Brijesh, Mukherjee
    Saurav, Patra
    [J]. JOURNAL OF DIABETES & METABOLISM, 2015, 6 (02)
  • [10] Effects of electroacupuncture on intestinal microflora and plasma metabolites in an insulin-resistant mouse model of type 2 diabetes mellitus
    Cao, Linhui
    Zhou, Sheng
    Li, Jianjun
    Chen, Kefang
    Xue, Xiaojin
    Yi, Wei
    [J]. ACUPUNCTURE IN MEDICINE, 2024, 42 (02) : 76 - 86